Clinical Trial Update: Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

View source ↗

Summary

This completed trial compared bone health effects of Copaxone versus interferon in people with multiple sclerosis, including those with low bone density.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Osteopenia

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• Interferon-beta (interferon beta)

Snippet

Sponsor: Nancy Hammond, MD | Conditions: Multiple Sclerosis, Low Bone Density | Status: COMPLETED